The brainstem noradrenergic systems in stress, anxiety and depression

Journal of Neuroendocrinology

Volumn 22, Issue 5, 2010, Pages 355-361

  Itoi, K ^a,b   Sugimoto, N ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

6 Hydroxydopamine; Depression; Dopamine hydroxylase; DSP 4; Locus coeruleus; Nucleus of the solitary tract

Indexed keywords

ANTIBODY; CORTICOTROPIN RELEASING FACTOR; DOPAMINE BETA MONOOXYGENASE; IMMUNOTOXIN; NORADRENALIN; SAPORIN;

ANXIETY DISORDER; BRAIN STEM; DEPRESSION; FOREBRAIN; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; LOCUS CERULEUS; NEUROENDOCRINE SYSTEM; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; STRESS; ANIMAL; ANXIETY; MENTAL STRESS; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANXIETY; BRAIN STEM; DEPRESSION; MICE; NOREPINEPHRINE; STRESS, PSYCHOLOGICAL;

EID: 77957352300     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2010.01988.x     Document Type: Review

References (65)

1. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive process. Brain Res Rev 2003; 42: 33-84.
2. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 2009; 10: 211-223.
3. Charney DS. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr Scand2003; 108(Suppl 417): 38-50.
4. Baldessarini RJ. Drug therapy of depression and anxiety disorders. In: Brunton LL, Lazo JS, Parker KL, eds. The Pharmacological Basis of Therapeutics, 11th edn. New York, NY: McGraw Hill, 2006: 429-459.
5. Pacák K, Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 2001; 22: 502-548.
6. Itoi K, Jiang YQ, Iwasaki Y, Watson SJ. Regulatory mechanisms of corticotropin-releasing hormoneand vasopressin gene expression in the hypothalamus. J Neuroendocrinol 2004; 16: 348-355.
7. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD Jr, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW.Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropinreleasing hormone. Proc Natl Acad Sci USA 2000; 97: 325-330.
8. Gold PW, Wong ML, Goldstein DS, Gold HK, Ronsaville DS, Esler M, Alesci S, Masood A, Licinio J, Geracioti TD Jr, Perini G, DeBellis MD, Holmes C, Vgontzas AN, Charney DS, Chrousos GP, McCann SM,Kling MA. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci USA 2005; 102: 8303-8308.
9. Dahlström A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamine in the cell bodies of brain stem neurons. Acta Physiol Scand 1964; 62(Suppl 232): 1-55.
10. Moore RY, Card LP. Noradrenaline-containing neuron systems. In: Björklund A, Hökfelt T, eds. Handbook of Chemical Neuroanatomy. Amsterdam: Elsevier, 1984: 123-156.
11. Cunningham ET, Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 1988; 274: 60-76.
12. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 2000; 403: 430-434.
13. Kostrzewa RM, Jacobowitz DM. Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 1974; 26: 199-288.
14. Jonsson G, Hallman H, Ponzio F, Ross S. DSP4 (N-(2chloroetyl)-N-ethyl-2-bromobenzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol 1981; 72:173-188.
15. Soto-Otero R, Me'ndez-Alvarez E, Hermida-Ameijeiras A, Muñoz-Patiño AM, Labandeira-Garcia JL. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem 2000; 74: 1605-1612.
16. Fritschy JM, Grzanna R. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in theadult rat brain. J Comp Neurol 1992; 321: 421-441.
17. Wiley RG, Kline RH IV. Neuronal lesioning with axonally transported toxins. J Neurosci Methods 2000; 103: 73-82.
18. Ritter S, Bugarith K, Dinh TT. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 2001; 432: 197-216.
19. Estacio MAC, Tsukamura H, Reyes BA, Uenoyama Y, I'anson H, Maeda K. Involvement of brainstem catecholaminergic inputs to the hypothalamic paraventricular nucleus in estrogen receptor alpha expression in this nucleus during different stress conditions in female rats. Endocrinology 2004; 145:4917-4926.
20. Rasmussen K, Jacobs BL. Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies. Brain Res 1986; 371: 335-344.
21. Rasmussen K, Morilak DA, Jacobs BL. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res 1986; 371: 324-334.
22. Pirnik Z, Mravec B, Kubovcakova L, Mikkelsen JD, Kiss A. Hypertonic saline and immobilization induce Fos expression in mouse brain catecholaminergic cell groups: colocalization with tyrosine hydroxylase and neuropeptide Y. Ann NY Acad Sci 2004; 1018: 398-404.
23. Chang MS, Sved AF, Zigmond MJ, Austin MC. Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience 2000; 101: 131-139.
24. Makino S, Smith MA, Gold PW. Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress. Brain Res 2002; 943: 216-223.
25. Jedema HP, Grace AA. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 2004; 24: 9703-9713.
26. Kawahara H, Kawahara Y, Westerink BH. The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain. Eur J Pharmacol 2000; 387: 279-286.
27. Yamada T, Mochiduki A, Sugimoto Y, Suzuki Y, Itoi K, Inoue K. Prolactinreleasing peptide regulates the cardiovascular system via corticotrophinreleasing hormone. J Neuroendocrinol 2009; 21: 586-593.
28. Redmond DE Jr, Huang YH, Snyder DR, Maas JW. Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey Macaca arctoides. Brain Res 1976; 116: 502-510.
29. Mason ST, Fibiger HC. Current concepts. I. Anxiety: the locus coeruleus disconnection. Life Sci 1979; 25: 2141-2147.
30. Harro J, Oreland L, Vasar E, Bradwejn J. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur Neuropsychopharmacol 1995; 5: 447-455.
31. Lapiz MD, Mateo Y, Durkin S, Parker T, Marsden CA. Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze. Psychopharmacology (Berl) 2001; 155: 251-259.
32. Gonzalez MM, Aston-Jones G. Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats. Proc Natl Acad Sci USA 2008; 105: 4898-4903.
33. Lähdesmäki J, Sallinen J, MacDonald E, Kobilka BK, Fagerholm V, Scheinin M. Behavioral and neurochemical characterization of a2A-adrenergic receptor knockout mice. Neuroscience 2002; 113: 289-299.
34. Schramm NL, McDonald MP, Limbird LE. The a2A-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 2001; 21: 4875-4882.
35. Shishkina GT, Kalinina TS, Sournina NY, Dygalo NN. Effects of antisense to the α2A-adrenoceptors administered into the region of the locus ceruleus on behaviors in plus-maze and sexual behaviortests in shamoperated and castrated male rats. J Neurosci 2001; 21: 726-731.
36. Marino MD, Bourdélat-Parks BN, Cameron Liles L , Weinshenker D. Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice. Behav Brain Res 2005; 161: 197-203.
37. Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA. Use of dopamine-β-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 2001; 298: 651-657.
38. Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci USA 2004; 101: 8186-8191.
39. Cryan JF, Page ME, Lucki I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 2002; 436: 197-205.
40. McGaugh JL. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 2004; 27: 1-28.
41. Chen FJ, Sara SJ. Locus coeruleus activation by foot shock or electrical stimulation inhibits amygdala neurons. Neuroscience 2007; 144: 472-481.
42. Hurlemann R, Hawellek B, Matusch A, Kolsch H, Wollersen H, Madea B, Vogeley K, Maier W, Dolan RJ. Noradrenergic modulation of emotioninduced forgetting and remembering. J Neurosci 2005; 25: 6343-6349.
43. Strange BA, Dolan RJ. Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. Proc Natl Acad Sci USA 2004; 101: 11454-11458.
44. van Stegeren AH, Goekoop R, Everaerd W, Scheltens P, Barkhof F, Kuijer JP, Rombouts SA. Noradrenaline mediates amygdala activation in men and women during encoding of emotional material. Neuroimage 2005; 24: 898-909.
45. Sterpenich V, D'Argembeau A, Desseilles M, Balteau E, Albouy G, Vandewalle G, Degueldre C, Luxen A, Collette F, Maquet P. The locus ceruleus is involved in the successful retrieval of emotionalmemories in humans. J Neurosci 2006; 26: 7416-7423.
46. Ziegler DR, Cass WA, Herman JP. Excitatory influence of the locus coeruleus in hypothalamic-pituitary-adrenocortical axis responses to stress. J Neuroendocrinol 1999; 11: 361-369.
47. Passerin AM, Cano G, Rabin BS, Delano BA, Napier JL, Sved AF. Role of locus coeruleus in foot shock-evoked Fos expression in rat brain. Neuroscience 2000; 101: 1071-1082.
48. Radley JJ, Williams B, Sawchenko PE. Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamo-pituitary-adrenal responses to acute emotional stress. J Neurosci 2008; 28: 5806-5816.
49. Pilowsky PM, Goodchild AK. Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 2002; 20: 1675-1688.
50. Guyenet PG. Neural structures that mediate sympathoexcitation during hypoxia. Respir Physiol 2000; 121: 147-162.
51. Burbach JPH, Luckman SM, Murphy D, Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 2001; 81: 1197-1267.
52. Rinaman L. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expressionin rats after gastric viscerosensory stimulation. J Neurosci 2003; 23: 10084-10092.
53. Pacak K, Palkovits M, Makino S, Kopin IJ, Goldstein DS. Brainstem hemisection decreases corticotropin-releasing hormone mRNA in the paraventricular nucleus but not in the central amygdaloid nucleus. J Neuroendocrinol 1996; 8: 543-551.
54. Li HY, Ericsson A, Sawchenko PE. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stressparadigms. Proc Natl Acad Sci USA 1996; 93: 2359-2364.
55. Li AJ, Wang Q, Ritter S. Differential responsiveness of dopamine-β-hydroxylase gene expression to glucoprivation in different catecholamine cell groups. Endocrinology 2006; 147: 3428-3434.
56. Itoi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abe K, Demura H. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasingfactor gene expression in conscious rats. Endocrinology 1994; 135: 2177-2182.
57. Itoi K, Helmreich DL, Lopez-Figueroa MO, Watson SJ. Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J Neurosci 1999; 19: 5464-5472.
58. Ma S, Morilak DA. Chronic intermittent cold stress sensitises the hypothalamic-pituitary-adrenal response to a novel acute stress by enhancing noradrenergic influence in the rat paraventricularnucleus. J Neuroendocrinol 2005; 17: 761-769.
59. Cecchi M, Khoshbouei H, Javors M, Morilak DA. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 2002; 112: 13-21.
60. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1214-1224.
61. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 1985; 241: 138-153.
62. Tauchi M, Zhang R, D'Alessio DA, Stern JE, Herman JP. Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei. J Chem Neuroanat 2008; 36: 144-149.
63. Das M, Vihlen CS, Legradi G. Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat. J Comp Neurol 2007; 500: 761-776.
64. Morales T, Hinuma S, Sawchenko PE. Prolactin-releasing peptide is expressed in afferents to theendocrine hypothalamus, but not in neurosecretory neurones. J Neuroendocrinol 2001; 12: 131-140.
65. Uchida K, Kobayashi D, Das G, Onaka T, Inoue K, Itoi K. Participation of the prolactin-releasing peptide-containing neurones in caudal medulla in conveying haemorrhagic stress-induced signals to the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 2010; 22: 33-42.